Medical pregnancy termination is possible in most women;IVG medicamenteuse: Possible chez la plupart des femmes

Revue du Praticien - Medecine Generale

Volumn 14, Issue 506, 2000, Pages 1377-1381

  Bureau, A ^a   Dagousset, I ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

CLINICAL PRACTICE; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MECHANISM; FEMALE; HOSPITALIZATION; HUMAN; PREGNANCY TERMINATION; PSYCHOLOGICAL ASPECT; SHORT SURVEY;

EID: 0034638052     PISSN: 09892737     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Recommandations medicales pour la securite d'utilisation de la mifepristone
2. Contraception and other clinical applications of RU 486 an antiprogesterone at the receptor
3. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy
4. Termination of early pregnancy (up to and after 49 days of amenorrhea) with mifepristone and increasing doses of misoprostol
5. L'avortement medicamenteuse par mifepristone misoprostol (Cytotec) en France
6. Early termination of pregnancy with mifepristone (RU Cytotec 48) and the orally active prostaglandine misoprostol
7. Mifepristone actualites perspectives
8. The efficacity and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK multicenter study. Final results
9. Interruption volontaire de grossesse; nouvelles perspectives de l'anesthesie locale